176750 — Duchembio Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Market Cap
KR₩273bn
Enterprise Value
KR₩275bn
Revenue
KR₩36bn

Annual balance sheet for Duchembio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,268	1,166	2,594	1,970	10,690
Net Total Accounts Receivable
Net Total Receivables	4,179	7,852	8,868	9,103	10,181
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	6,320	10,453	12,331	12,668	22,240
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	18,055	26,995	17,978	16,186	16,712
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	25,064	59,986	51,351	49,277	65,168
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	25,372	30,196	24,187	19,357	14,925
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	32,720	39,132	33,757	27,482	22,159
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	-7,655	20,854	17,594	21,794	43,010
Total Liabilities & Shareholders' Equity	25,064	59,986	51,351	49,277	65,168
Total Common Shares Outstanding